Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-β Pathology in APP/PS1 MiceJOURNAL OF ALZHEIMERS DISEASEIF3.12024-01-022PRE
Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis (vol 55, pg 215, 2023)EXPERIMENTAL AND MOLECULAR MEDICINEIF12.92023-02-151OAAI
Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosisEXPERIMENTAL AND MOLECULAR MEDICINEIF12.92023-01-1311OAAI
Muramyl Dipeptide Administration Delays Alzheimer's Disease Physiopathology via NOD2 ReceptorsCELLSIF5.22022-07-199OAAI
Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent MannerFRONTIERS IN IMMUNOLOGYIF5.92022-01-3119OAAI
Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer DiseasePHARMACOLOGICAL REVIEWSIF17.32022-01-0123OAAI
Triggering Innate Immune Receptors as New Therapies in Alzheimer's Disease and Multiple SclerosisCELLSIF5.22021-08-225OAAI
The Intellicage system provides a reproducible and standardized method to assess behavioral changes in cuprizone-induced demyelination mouse modelBEHAVIOURAL BRAIN RESEARCHIF2.32021-02-015PREAI
Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer's diseaseALZHEIMERS RESEARCH & THERAPYIF7.62021-01-0534OAAI
Beneficial Roles of Microglia and Growth Factors in MS, a Brief ReviewFRONTIERS IN CELLULAR NEUROSCIENCEIF42020-09-2320OAAI
Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS DiseasesCELLSIF5.22020-07-0141OAAI
Role of Macrophage Colony-Stimulating Factor Receptor on the Proliferation and Survival of Microglia Following Systemic Nerve and Cuprizone-Induced InjuriesFRONTIERS IN IMMUNOLOGYIF5.92020-01-2928OAAI
New Therapeutic Avenues of mCSF for Brain Diseases and InjuriesFRONTIERS IN CELLULAR NEUROSCIENCEIF42018-12-2028OAAI